HRP20030410B1 - Freeze dried pantoprazole preparation and pantoprazole injection - Google Patents

Freeze dried pantoprazole preparation and pantoprazole injection

Info

Publication number
HRP20030410B1
HRP20030410B1 HR20030410A HRP20030410A HRP20030410B1 HR P20030410 B1 HRP20030410 B1 HR P20030410B1 HR 20030410 A HR20030410 A HR 20030410A HR P20030410 A HRP20030410 A HR P20030410A HR P20030410 B1 HRP20030410 B1 HR P20030410B1
Authority
HR
Croatia
Prior art keywords
pantoprazole
salt
preparation
injection
freeze dried
Prior art date
Application number
HR20030410A
Other languages
English (en)
Croatian (hr)
Inventor
Linder Rudolf
Dietrich Rango
Original Assignee
Nycomed Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8170452&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20030410(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nycomed Gmbh filed Critical Nycomed Gmbh
Publication of HRP20030410A2 publication Critical patent/HRP20030410A2/hr
Publication of HRP20030410B1 publication Critical patent/HRP20030410B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
HR20030410A 2000-11-22 2003-05-21 Freeze dried pantoprazole preparation and pantoprazole injection HRP20030410B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00125569 2000-11-22
PCT/EP2001/013296 WO2002041919A1 (en) 2000-11-22 2001-11-17 Freeze-dried pantoprazole preparation and pantoprazole injection

Publications (2)

Publication Number Publication Date
HRP20030410A2 HRP20030410A2 (en) 2005-04-30
HRP20030410B1 true HRP20030410B1 (en) 2011-02-28

Family

ID=8170452

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20030410A HRP20030410B1 (en) 2000-11-22 2003-05-21 Freeze dried pantoprazole preparation and pantoprazole injection

Country Status (40)

Country Link
US (3) US6780881B2 (es)
EP (2) EP1339430B1 (es)
JP (1) JP4886158B2 (es)
KR (2) KR100910606B1 (es)
CN (1) CN1250292C (es)
AR (2) AR034277A1 (es)
AT (1) ATE381946T1 (es)
AU (2) AU2002216042B2 (es)
BG (1) BG66329B1 (es)
BR (1) BRPI0115483B8 (es)
CA (2) CA2541946A1 (es)
CY (1) CY1107896T1 (es)
CZ (1) CZ304348B6 (es)
DE (1) DE60132108T2 (es)
DK (1) DK1339430T3 (es)
EA (1) EA007602B1 (es)
EC (1) ECSP034613A (es)
EE (1) EE05236B1 (es)
ES (1) ES2298295T3 (es)
GE (1) GEP20053461B (es)
HK (1) HK1060848A1 (es)
HR (1) HRP20030410B1 (es)
HU (1) HUP0303278A3 (es)
IL (2) IL155601A0 (es)
IS (1) IS2971B (es)
ME (1) ME00556B (es)
MX (1) MXPA03004548A (es)
MY (1) MY137726A (es)
NO (1) NO332937B1 (es)
NZ (1) NZ525911A (es)
PE (1) PE20020582A1 (es)
PL (1) PL201188B1 (es)
PT (1) PT1339430E (es)
RS (1) RS52024B (es)
SI (1) SI1339430T1 (es)
SK (1) SK287993B6 (es)
TW (1) TWI284041B (es)
UA (1) UA80961C2 (es)
WO (1) WO2002041919A1 (es)
ZA (1) ZA200303593B (es)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY137726A (en) 2000-11-22 2009-03-31 Nycomed Gmbh Freeze-dried pantoprazole preparation and pantoprazole injection
US20050287231A1 (en) * 2002-06-21 2005-12-29 Nussen Kenneth H Method and apparatus for oral hygiene products with green tea extract
KR20050071611A (ko) * 2002-10-25 2005-07-07 화이자 프로덕츠 인코포레이티드 현탁액 형태의 아릴헤테로환 활성제의 저장 제형
AU2003241150A1 (en) * 2003-05-06 2004-11-26 Hetero Drugs Limited Novel polymorphs of pantoprazole sodium
CL2004000983A1 (es) * 2003-05-08 2005-03-04 Altana Pharma Ag Composicion farmaceutica oral en forma de tableta que comprende a pantoprazol magnetico dihidratado, en donde la forma de tableta esta compuesto por un nucleo, una capa intermedia y una capa exterior; y uso de la composicion farmaceutica en ulceras y
EP1631284A2 (en) * 2003-05-19 2006-03-08 Pliva-Istrazivanje I Razvoj D.D.O. Solid-state forms of 5-(difluoromethoxy)-2-((3,4-dimethoxy-2-pyridinyl)methyl)sulfinyl)-1h-benzimidazole (pantoprazole) sodium aqua complexes
AR045258A1 (es) * 2003-08-21 2005-10-19 Altana Pharma Ag Un producto farmaceutico para inyeccion
WO2005070426A1 (en) * 2004-01-27 2005-08-04 Altana Pharma Ag Freeze-dried (-)-pantoprazole preparation and (-)-pantoprazole injection
DE102004007854A1 (de) * 2004-02-17 2005-09-01 Hexal Ag Stabile, wässrige Formulierung für Benzimidazole
US20060085924A1 (en) * 2004-10-13 2006-04-27 Gaelle Brun Coloring composition comprising at least one pigment and at least one electrophilic cyanoacrylate monomer
CN1293879C (zh) * 2005-01-20 2007-01-10 杭州华东医药集团生物工程研究所有限公司 泮托拉唑钠冻干粉针剂及其制备方法
JP2009511481A (ja) * 2005-10-06 2009-03-19 オースペックス・ファーマシューティカルズ・インコーポレイテッド 増強された治療特性を持つ、胃Ｈ＋，Ｋ＋−ＡＴＰａｓｅの重水素化阻害剤
AR061155A1 (es) * 2006-06-01 2008-08-06 Combino Pharm Sl Preparaciones liofilizadas de pantoprazol sodico para inyeccion
EP2049142B2 (en) 2006-07-26 2016-01-20 Sandoz AG Caspofungin formulations
US7979200B2 (en) * 2006-11-20 2011-07-12 Lockheed Martin Corporation Managing an air-ground communications network with air traffic control information
EP2106788A1 (en) * 2008-04-04 2009-10-07 Ipsen Pharma Liquid and freeze dried formulations
CN101744777B (zh) * 2009-12-30 2012-09-26 北京四环科宝制药有限公司 奥美拉唑钠冻干粉针剂及制备方法和检测方法
CN101961309B (zh) * 2010-09-15 2012-06-27 河南辅仁怀庆堂制药有限公司 注射用泮托拉唑钠配制工艺
CN102000034B (zh) * 2010-10-13 2011-12-21 江苏奥赛康药业股份有限公司 一种供注射用的s-泮托拉唑钠组合物及其制备方法
CN102225063B (zh) * 2011-05-10 2012-10-10 江苏奥赛康药业股份有限公司 一种供注射用的泮托拉唑钠组合物
TR201108946A2 (tr) * 2011-09-12 2012-04-24 World Medicine İlaç Sanayi̇ Ve Ti̇caret Li̇mi̇ted Şi̇rketi̇ Dondurularak kurutulmuş atp, vitamin b kompleksi preparatı ve enjeksiyonu.
UY34880A (es) * 2012-06-27 2014-01-31 Takeda Pharmaceutical Preparación líquida
CN104000786A (zh) * 2013-02-25 2014-08-27 杭州赛利药物研究所有限公司 泮托拉唑钠冻干制剂及其制备方法
CN104414979A (zh) * 2013-08-21 2015-03-18 哈药集团三精制药股份有限公司 一种泮托拉唑钠冻干粉针剂及其制备方法
CN104019635B (zh) * 2014-06-19 2015-05-27 上海慈瑞医药科技有限公司 一种兰索拉唑原料药化合物及其干燥工艺
CN104055792A (zh) * 2014-07-10 2014-09-24 北京人福军威医药技术开发有限公司 西地碘治疗中耳炎的用途
CN104055791A (zh) * 2014-07-10 2014-09-24 北京人福军威医药技术开发有限公司 西地碘治疗眼角结膜炎的用途
BE1021311B1 (nl) * 2014-07-31 2015-10-28 Neogen N.V. Werkwijze voor het maken van een poedervormige protonpompremmer samenstelling, genoemde samenstelling en gebruik
US20170042806A1 (en) 2015-04-29 2017-02-16 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
CN111643460A (zh) * 2020-06-30 2020-09-11 武汉九州钰民医药科技有限公司 泮托拉唑钠冻干制剂及其制备方法、由其制得的注射制剂
CN112274481A (zh) * 2020-10-27 2021-01-29 海南卫康制药(潜山)有限公司 一种注射用泮托拉唑钠组合物及其制备方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4324014A1 (de) * 1993-07-17 1995-01-19 Byk Gulden Lomberg Chem Fab Verfahren zur Herstellung einer in Wasser rekonstituierbaren Zubereitung

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8301182D0 (sv) * 1983-03-04 1983-03-04 Haessle Ab Novel compounds
IL75400A (en) * 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
US5223515A (en) * 1988-08-18 1993-06-29 Takeda Chemical Industries, Ltd. Injectable solution containing a pyridyl methylsulfinylbenzimidazole
DK399389A (da) 1988-08-18 1990-02-19 Takeda Chemical Industries Ltd Injicerbare oploesninger
DE4035455A1 (de) 1990-11-08 1992-05-14 Byk Gulden Lomberg Chem Fab Enantiomerentrennung
AU674015B2 (en) 1992-07-28 1996-12-05 Astra Aktiebolag Injection and injection kit containing omeprazole and its analogs
WO1994024867A1 (en) * 1993-04-27 1994-11-10 Sepracor, Inc. Methods and compositions for treating gastric disorders using optically pure (-) pantoprazole
TW280770B (es) * 1993-10-15 1996-07-11 Takeda Pharm Industry Co Ltd
HU224987B1 (en) 1995-11-03 2006-05-29 Sanofi Aventis Stable freeze-dried pharmaceutical formulation
FR2740686B1 (fr) * 1995-11-03 1998-01-16 Sanofi Sa Formulation pharmaceutique lyophilisee stable
US5980882A (en) 1997-04-16 1999-11-09 Medeva Pharmaceuticals Manufacturing Drug-resin complexes stabilized by chelating agents
DE69835165T2 (de) 1997-10-14 2007-06-06 Eisai Co., Ltd. Pharmazeutische Formulierung, die Glycin als Stabilisator umfasst
DE19843413C1 (de) * 1998-08-18 2000-03-30 Byk Gulden Lomberg Chem Fab Neue Salzform von Pantoprazol
WO2000026185A2 (en) 1998-10-30 2000-05-11 The Curators Of The University Of Missouri Omeprazole solution and method of using same
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
CN1235018A (zh) * 1999-04-22 1999-11-17 沈阳东宇药业有限公司 泮托拉唑钠冻干粉针剂及制备方法
SE9903831D0 (sv) * 1999-10-22 1999-10-22 Astra Ab Formulation of substituted benzimidazoles
EP1310252A4 (en) * 2000-08-18 2009-06-10 Takeda Pharmaceutical INJECTIONS
MY137726A (en) * 2000-11-22 2009-03-31 Nycomed Gmbh Freeze-dried pantoprazole preparation and pantoprazole injection
AR045258A1 (es) 2003-08-21 2005-10-19 Altana Pharma Ag Un producto farmaceutico para inyeccion

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4324014A1 (de) * 1993-07-17 1995-01-19 Byk Gulden Lomberg Chem Fab Verfahren zur Herstellung einer in Wasser rekonstituierbaren Zubereitung

Also Published As

Publication number Publication date
IS2971B (is) 2017-05-15
IL155601A0 (en) 2003-11-23
EE05236B1 (et) 2009-12-15
ZA200303593B (en) 2004-04-23
ME00556A (en) 2011-12-20
JP2004513970A (ja) 2004-05-13
AR092374A2 (es) 2015-04-15
US8754108B2 (en) 2014-06-17
MY137726A (en) 2009-03-31
CY1107896T1 (el) 2013-09-04
RS52024B (sr) 2012-04-30
CZ20031416A3 (cs) 2003-09-17
CN1476335A (zh) 2004-02-18
CA2428870A1 (en) 2002-05-30
EP1762249A3 (en) 2014-05-14
US20030003058A1 (en) 2003-01-02
TWI284041B (en) 2007-07-21
PL361118A1 (en) 2004-09-20
DK1339430T3 (da) 2008-05-13
IS6820A (is) 2003-05-19
AR034277A1 (es) 2004-02-18
DE60132108T2 (de) 2008-12-11
EP1762249A2 (en) 2007-03-14
NO332937B1 (no) 2013-02-04
CZ304348B6 (cs) 2014-03-19
KR100910607B1 (ko) 2009-08-04
NO20032303L (no) 2003-05-21
US20040220228A1 (en) 2004-11-04
BG66329B1 (bg) 2013-06-28
SK6062003A3 (en) 2003-10-07
EA007602B1 (ru) 2006-12-29
UA80961C2 (en) 2007-11-26
EP1339430B1 (en) 2007-12-26
WO2002041919A1 (en) 2002-05-30
JP4886158B2 (ja) 2012-02-29
PT1339430E (pt) 2008-03-27
IL155601A (en) 2008-12-29
YU37703A (sh) 2006-05-25
SK287993B6 (sk) 2012-09-03
KR20080003010A (ko) 2008-01-04
BRPI0115483B1 (pt) 2017-05-09
AU2002216042B2 (en) 2006-08-03
KR20030055308A (ko) 2003-07-02
BG107828A (bg) 2004-07-30
US6780881B2 (en) 2004-08-24
EE200300182A (et) 2003-06-16
KR100910606B1 (ko) 2009-08-04
DE60132108D1 (de) 2008-02-07
HUP0303278A2 (hu) 2004-01-28
PE20020582A1 (es) 2002-07-06
ME00556B (me) 2011-12-20
HRP20030410A2 (en) 2005-04-30
CA2541946A1 (en) 2002-05-30
BRPI0115483B8 (pt) 2021-05-25
CN1250292C (zh) 2006-04-12
EP1339430A1 (en) 2003-09-03
NZ525911A (en) 2004-11-26
ECSP034613A (es) 2003-08-29
US7351723B2 (en) 2008-04-01
GEP20053461B (en) 2005-02-25
ATE381946T1 (de) 2008-01-15
SI1339430T1 (sl) 2008-06-30
ES2298295T3 (es) 2008-05-16
HUP0303278A3 (en) 2007-08-28
MXPA03004548A (es) 2003-09-10
PL201188B1 (pl) 2009-03-31
HK1060848A1 (en) 2004-08-27
US20090093522A1 (en) 2009-04-09
BR0115483A (pt) 2003-10-21
EA200300501A1 (ru) 2003-12-25
NO20032303D0 (no) 2003-05-21
AU1604202A (en) 2002-06-03
CA2428870C (en) 2006-05-23

Similar Documents

Publication Publication Date Title
HRP20030410B1 (en) Freeze dried pantoprazole preparation and pantoprazole injection
DE60123800D1 (de) Salze von benzimidazol-derivaten und deren verwendung
KR950702419A (ko) 오메프라졸 및 그의 동족체를 함유하는 주사제 및 주사제 키트(injection and injection kit containing omeprazole and its analogs)
IS4161A (is) Aðferð til að útbúa ljósfræðilega hrein Na+, Mg2+, Li+, K+ eða Ca2+ sölt (-)-5-metoxý-2-[[(4-metoxý-3,5-dímetýl-2-pýridínýl)metýl]súlfinýl]-1H-bensimídasóls og milliefnasamband.
HRP20020306B1 (en) 6-position substituted indole, production and use thereof as a medicament
ES2195345T3 (es) Nueva forma de s-omeprazol.
DE60020967D1 (de) Kristalle von lansoprazole
HRP20010117B1 (en) Novel salt form of pantoprazole
DK0533790T3 (da) Hidtil ukendt saltform af 5-difluormethoxy-2-((3,4-dimethoxy-2-pyridyl)methylsulfinyl)-1H-benzimidazol
DK1254118T3 (da) Substituerede 1,2,3,4-tetrahudroquinolin-2-carboxylsyrederivater
ATE338027T1 (de) Herstellung von iminodiessigsäure-derivaten aus monoethanolamin-substraten
ATE288922T1 (de) Bestimmte heteroaryl substituierte thiol inhibitoren von endothelin wechselnden enzymen
WO2003101452A8 (en) Process for the preparation of highly pure rabeprazole sodium salt
DK1237415T3 (da) Koagulationsoplösning til koagulation af kollagen
DE59706535D1 (de) Verfahren zur Herstellung von wasserlöslichen Celluloseethern unter Rückgewinnung von Natriumhydroxid
SE9000872D0 (sv) Sulfonyl derivatives of thieno-triazolo-diazepines, a preparation process of the same and therapeutic compositions containing them
DK1399138T3 (da) Fremgangsmåde til fremstilling af faste formuleringer af natrium-3-hydroxy-3-methylbutyrat
CO4970704A1 (es) Solucion acuosa estable de em 12, y procedimiento de preparacion de dicha solucion
DE69618496T2 (de) Verfahren zur Derivatisierung von Polyglukosaminen
DE60108760D1 (de) Beschichtung von tabletten
ATE386136T1 (de) Verwendung der acetylaminosäureracemase aus amycolatopsis orientalis zur racemisierung von carbamoylaminosäuren
RU2001103076A (ru) Способ глушения скважин
DK1120117T3 (da) Fremgangsmåde til at öge produktionen af æg og forstærke æggeskal hos fjerkræ
TH69761B (th) ผลึกสารประกอบเบนซิมิแดซอล
RU2002109760A (ru) Способ получения композиции на основе метилцеллюлозы

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
PNAN Change of the applicant name, address/residence

Owner name: NYCOMED GMBH, DE

B1PR Patent granted
PNAN Change of the applicant name, address/residence

Owner name: TAKEDA GMBH, DE

PNAN Change of the applicant name, address/residence

Owner name: NYCOMED ASSET MANAGEMENT GMBH, DE

Owner name: NYCOMED GERMANY HOLDING GMBH, DE

Owner name: TAKEDA GMBH, DE

ODRP Renewal fee for the maintenance of a patent

Payment date: 20190927

Year of fee payment: 19

ODRP Renewal fee for the maintenance of a patent

Payment date: 20201029

Year of fee payment: 20

PB20 Patent expired after termination of 20 years

Effective date: 20211117